Welcome to our dedicated page for Moelis & Co SEC filings (Ticker: MC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles Moelis & Company (NYSE: MC) SEC filings, giving investors structured access to the firm’s regulatory disclosures as a global independent investment bank in the investment banking and securities dealing industry. Filings such as Form 8-K, Form 10-K, Form 10-Q, and Form 4 provide insight into Moelis & Company’s financial performance, governance, and insider activity.
Moelis & Company uses Current Reports on Form 8-K to announce material events, including quarterly financial results and board changes. For example, the company files 8-Ks when it releases earnings for specific quarters and when its Board elects a new independent director, detailing items such as results of operations, updated investor presentations, and director compensation arrangements.
Investors can look to the firm’s annual reports on Form 10-K and quarterly reports on Form 10-Q (when available on this page) for more comprehensive information on revenues, expenses, net income, segment drivers, and risk factors. Moelis & Company also discusses its use of Adjusted (non-GAAP) metrics in conjunction with GAAP results, and its filings reference the ownership structure of Moelis & Company Group LP and related tax treatment.
In addition, Form 4 insider transaction reports, when present, can help users track purchases, sales, and equity awards involving Moelis & Company’s directors and executive officers. Proxy-related filings may further describe board composition, director independence, and compensation practices, as illustrated by the firm’s disclosure of compensation for an independent director in a Form 8-K.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, explain complex sections in simpler language, and surface notable items such as changes in revenues, margins, dividends, or governance. With real-time updates from EDGAR and organized access to 10-Ks, 10-Qs, 8-Ks, and Form 4s, this page helps users quickly understand what Moelis & Company is reporting to regulators and how those disclosures relate to its advisory-focused business model.
Moelis & Company (NYSE: MC) filed a Form 8-K on July 1, 2025 announcing the election of Thorold Barker as an independent director, effective the same day. The Board confirmed that Barker meets both NYSE independence standards and SEC Rule 10A-3 criteria and immediately appointed him to all Board committees.
Under the firm’s standard non-employee director program, Barker will receive total annual compensation of $200,000, split between (i) $100,000 in cash and/or Class A shares at his discretion and (ii) $100,000 in fully vested Restricted Stock Units that will settle two years after grant (initial grant settles no later than 60 days after July 1, 2026). He will also be reimbursed for reasonable meeting expenses and has executed the company’s customary indemnification agreement.
The company furnished a press release as Exhibit 99.1 under Item 7.01 but disclosed no financial results, strategic transactions, or other material events.
Director Laila Worrell of Moelis & Co (MC) received multiple Restricted Stock Unit (RSU) grants as dividend equivalents on June 20, 2025. The transactions include:
- 2023 Annual RSUs: Acquired 28.86 units, bringing total holdings to 2,540.35 units
- 2024 Annual RSUs: Acquired 22.89 units, total holdings now 2,014.62 units
- 2024 Elective RSUs: Acquired 3.14 units, total holdings reached 276.52 units
All RSUs represent the right to receive one share of Class A Common Stock. These grants were issued as dividend equivalents on previously awarded RSUs from July 2023 and July 2024. The dividend equivalent RSUs will vest simultaneously with their underlying RSU awards. All securities are held directly by the reporting person.
Director Kenneth Shropshire of Moelis & Co (MC) received multiple restricted stock unit (RSU) grants as dividend equivalents on June 20, 2025. The transactions include:
- 2,661.12 units of 2023 Annual RSUs, issued as dividend equivalents on RSUs originally granted July 3, 2023
- 2,110.26 units of 2024 Annual RSUs, issued as dividend equivalents on RSUs originally granted July 1, 2024
- 62.37 units of 2024 Elective RSUs, issued as dividend equivalents on RSUs originally granted July 1, 2024
Each RSU represents the right to receive one share of Class A Common Stock. All dividend equivalent RSUs will vest concurrently with their underlying RSU grants. These transactions represent standard dividend equivalent distributions rather than new equity compensation awards, maintaining the director's alignment with shareholder interests.